In focus · trending topic

PTCT Therapeutics

1 stories · following the connections

Hagens Berman Reminds PTCT Therapeutics (NASDAQ: PTCT) Investors of May 2, 2016 Lead Plaintiff Deadline and Longer Class Period

By Nasdaq OMXApr 4, 2016, 12:30 PM UTC